Accreditation, Ratings & Awards
What you need to know about COVID-19
End of Life Option Act
Mission, Vision, Values
Notice of Privacy Incident
News and Publications
Understanding Clinical Trials
Hello Humankindness Student Ambassador Program
St. Joseph's Heart & Vascular Institute is home to one of the largest and most recognized cardiovascular care teams in the state, and includes a multidisciplinary TAVR team. The TAVR physicians have extensive experience and are trained to implant various FDA-approved devices. We offer additional technology through clinical research trials.
Aortic Stenosis is a progressive narrowing of the aortic valve resulting in reduction of blood flow out of the heart. TAVR is a minimally invasive procedure that treats aortic stenosis without requiring open heart surgery. The valve is placed on a catheter, inserted into an artery and advance to the narrowed aortic valve for deployment. TAVR is FDA-approved for patients considered intermediate to high-risk for surgical aortic valve replacement.
During TAVR, your surgeon will place the valve on a catheter which is inserted into an artery in the groin, rather than through an opening in the chest. The valve is threaded inside the faulty aortic valve and inflated. TAVR patients typically recover faster with less pain than patients undergoing open chest valve replacement.